| 1 |
Adempas |
- |
- |
- |
- |
051 [5] 51, 86, 88, 225, 299 💬 |
| 2 |
Adempas (riociguat, bay63-2521) |
Riociguat |
[1] D09572 D09572 💬 |
GUCY1A1 [3] GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
086 [2] 86, 88 💬 |
| 3 |
Adempas - 0,5 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse |
- |
- |
- |
- |
086 [1] 86 💬 |
| 4 |
Adempas - 1 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
| 5 |
Adempas - 1,5 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
| 6 |
Adempas - 2 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
| 7 |
Adempas - 2,5 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
| 8 |
Adempas 0.125 mg |
- |
- |
- |
- |
299 [1] 299 💬 |
| 9 |
Adempas 0.5 mg |
- |
- |
- |
- |
086 [2] 86, 299 💬 |
| 10 |
Adempas 0.5 mg film coated tablet |
- |
- |
- |
- |
086 [1] 86 💬 |
| 11 |
Adempas 1 mg film coated tablet |
- |
- |
- |
- |
086 [1] 86 💬 |
| 12 |
Adempas 1.0 mg |
- |
- |
- |
- |
086 [2] 86, 299 💬 |
| 13 |
Adempas 1.5 mg |
- |
- |
- |
- |
086 [1] 86 💬 |
| 14 |
Adempas 1.5 mg film coated tablet |
- |
- |
- |
- |
086 [1] 86 💬 |
| 15 |
Adempas 2 mg film coated tablet |
- |
- |
- |
- |
086 [1] 86 💬 |
| 16 |
Adempas 2.0 mg |
- |
- |
- |
- |
086 [2] 86, 299 💬 |
| 17 |
Adempas 2.5 mg |
- |
- |
- |
- |
086 [1] 86 💬 |
| 18 |
Adempas 2.5 mg film coated tablet |
- |
- |
- |
- |
086 [1] 86 💬 |
| 19 |
Adempas® |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
| 20 |
Adempas® 0.5 mg film-coated tablets |
- |
- |
- |
- |
086 [1] 86 💬 |
| 21 |
Adempas® 1.0 mg film-coated tablets |
- |
- |
- |
- |
086 [1] 86 💬 |
| 22 |
Adempas® 1.5 mg film-coated tablets |
- |
- |
- |
- |
086 [1] 86 💬 |
| 23 |
Adempas® 2.0 mg film-coated tablets |
- |
- |
- |
- |
086 [1] 86 💬 |
| 24 |
Adempas® 2.5 mg film-coated tablets |
- |
- |
- |
- |
086 [1] 86 💬 |
| 25 |
Adempas¿ 0.5 mg compressa rivestita con film |
- |
- |
- |
- |
086 [1] 86 💬 |
| 26 |
Adempas¿ 1.0 |
- |
- |
- |
- |
086 [1] 86 💬 |
| 27 |
Adempas¿ 1.5 mg |
- |
- |
- |
- |
086 [1] 86 💬 |
| 28 |
Adempas¿ 2.0 mg |
- |
- |
- |
- |
086 [1] 86 💬 |
| 29 |
Adempas¿ 2.5 mg |
- |
- |
- |
- |
086 [1] 86 💬 |
| 30 |
Riociguat |
Riociguat |
[1] D09572 D09572 💬 |
GUCY1A1 [3] GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
051 [6] 51, 84, 86, 88, 225, 299 💬 |
| 31 |
Riociguat (adempas, bay63-2521) |
Riociguat |
[1] D09572 D09572 💬 |
GUCY1A1 [3] GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
051 [4] 51, 86, 88, 299 💬 |
| 32 |
Riociguat (bay63-2521) |
Riociguat |
[1] D09572 D09572 💬 |
GUCY1A1 [3] GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
| 33 |
Riociguat coated tablet 0.5 mg |
Riociguat |
[1] D09572 D09572 💬 |
GUCY1A1 [3] GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
051 [1] 51 💬 |
| 34 |
Riociguat coated tablet 1.0 mg |
Riociguat |
[1] D09572 D09572 💬 |
GUCY1A1 [3] GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
051 [1] 51 💬 |
| 35 |
Riociguat coated tablet 1.5 mg |
Riociguat |
[1] D09572 D09572 💬 |
GUCY1A1 [3] GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
051 [1] 51 💬 |
| 36 |
Riociguat coated tablet 2.0 mg |
Riociguat |
[1] D09572 D09572 💬 |
GUCY1A1 [3] GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
051 [1] 51 💬 |
| 37 |
Riociguat coated tablet 2.5 m |
Riociguat |
[1] D09572 D09572 💬 |
GUCY1A1 [3] GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
051 [1] 51 💬 |
| 38 |
Riociguat coated tablet 2.5 mg |
Riociguat |
[1] D09572 D09572 💬 |
GUCY1A1 [3] GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
051 [1] 51 💬 |
| 39 |
Riociguat granules 0.3% for oral application |
Riociguat |
[1] D09572 D09572 💬 |
GUCY1A1 [3] GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
| 40 |
Riociguat oral product |
Riociguat |
[1] D09572 D09572 💬 |
GUCY1A1 [3] GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
| 41 |
Riociguat oral tablet |
Riociguat |
[1] D09572 D09572 💬 |
GUCY1A1 [3] GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
088 [1] 88 💬 |
| 42 |
Riociguat pill |
Riociguat |
[1] D09572 D09572 💬 |
GUCY1A1 [3] GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
086 [1] 86 💬 |